Latest news for Biotest (OTC:BIESF) Stock

Biotest AG is a supplier of biological medicines. The company produces its products from human blood plasma or manufactured by using biotechnology methods. It is engaged in the area of hematology, clinical immunology, and intensive care medicine. The operating business segments are Therapy, Plasma and Services, and Other segments. It generates maximum revenue from the Therapy segment. Geographically, it derives a majority of revenue from Central Europe and also has a presence in other countries.

Comments

Biotest

News

Latest news for Biotest (OTC:BIESF) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga